nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Ticagrelor—coronary artery disease	0.0814	0.146	CbGbCtD
Rifaximin—CYP3A4—Fenofibrate—coronary artery disease	0.0726	0.13	CbGbCtD
Rifaximin—CYP3A4—Gemfibrozil—coronary artery disease	0.058	0.104	CbGbCtD
Rifaximin—CYP3A4—Clopidogrel—coronary artery disease	0.0503	0.0904	CbGbCtD
Rifaximin—CYP3A4—Eplerenone—coronary artery disease	0.0468	0.0841	CbGbCtD
Rifaximin—CYP3A4—Enalapril—coronary artery disease	0.0417	0.0749	CbGbCtD
Rifaximin—CYP3A4—Rosuvastatin—coronary artery disease	0.0324	0.0583	CbGbCtD
Rifaximin—CYP3A4—Ezetimibe—coronary artery disease	0.0324	0.0583	CbGbCtD
Rifaximin—CYP3A4—Simvastatin—coronary artery disease	0.0301	0.0542	CbGbCtD
Rifaximin—CYP3A4—Pravastatin—coronary artery disease	0.0295	0.053	CbGbCtD
Rifaximin—CYP3A4—Lovastatin—coronary artery disease	0.0295	0.053	CbGbCtD
Rifaximin—CYP3A4—Atorvastatin—coronary artery disease	0.0269	0.0483	CbGbCtD
Rifaximin—CYP3A4—Losartan—coronary artery disease	0.0246	0.0442	CbGbCtD
Rifaximin—Rifabutin—HSP90B1—coronary artery disease	0.0104	0.959	CrCbGaD
Rifaximin—NR1I2—Nuclear Receptors—RXRG—coronary artery disease	0.00263	0.0858	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—RXRG—coronary artery disease	0.00208	0.0678	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.00179	0.0582	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR3C2—coronary artery disease	0.00177	0.0576	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—NR4A1—coronary artery disease	0.00154	0.0503	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR4A1—coronary artery disease	0.00122	0.0397	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.00107	0.0347	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—ESR2—coronary artery disease	0.00101	0.0329	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—ESR2—coronary artery disease	0.000797	0.026	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—ESR1—coronary artery disease	0.000612	0.0199	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	0.00061	0.0199	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARG—coronary artery disease	0.000558	0.0182	CbGpPWpGaD
Rifaximin—CYP3A4—Liver X Receptor Pathway—ABCG5—coronary artery disease	0.00055	0.0179	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—ESR1—coronary artery disease	0.000484	0.0158	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—SULT1E1—coronary artery disease	0.000459	0.0149	CbGpPWpGaD
Rifaximin—Rifampicin—CYP2C19—coronary artery disease	0.000443	0.0407	CrCbGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARG—coronary artery disease	0.000441	0.0144	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—SULT1E1—coronary artery disease	0.000406	0.0132	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—TBX5—coronary artery disease	0.000359	0.0117	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—RXRG—coronary artery disease	0.000359	0.0117	CbGpPWpGaD
Rifaximin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—coronary artery disease	0.000349	0.0114	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—SULT1A1—coronary artery disease	0.000343	0.0112	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—GSTA1—coronary artery disease	0.000335	0.0109	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NKX2-5—coronary artery disease	0.000314	0.0102	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR3C2—coronary artery disease	0.000306	0.00996	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—SULT1A1—coronary artery disease	0.000304	0.00989	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—coronary artery disease	0.000297	0.00968	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AIMP1—coronary artery disease	0.00028	0.00913	CbGpPWpGaD
Rifaximin—CYP3A4—Xenobiotics—CYP2C19—coronary artery disease	0.000242	0.00789	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP2C19—coronary artery disease	0.000233	0.00759	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—TET1—coronary artery disease	0.000228	0.00744	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—GATA4—coronary artery disease	0.00022	0.00718	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—coronary artery disease	0.000217	0.00706	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR4A1—coronary artery disease	0.000211	0.00687	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.000207	0.00673	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NPPA—coronary artery disease	0.000192	0.00625	CbGpPWpGaD
Rifaximin—CYP3A4—Aflatoxin activation and detoxification—GGT1—coronary artery disease	0.00019	0.00619	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—HADH—coronary artery disease	0.000173	0.00564	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RXRG—coronary artery disease	0.000173	0.00564	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—TBX5—coronary artery disease	0.000173	0.00564	CbGpPWpGaD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—coronary artery disease	0.000169	0.00551	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—coronary artery disease	0.000166	0.00542	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—GSTM1—coronary artery disease	0.000164	0.00534	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NKX2-5—coronary artery disease	0.000151	0.00493	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—CTGF—coronary artery disease	0.000151	0.00491	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SMG6—coronary artery disease	0.000147	0.00479	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR3C2—coronary artery disease	0.000147	0.00479	CbGpPWpGaD
Rifaximin—Arthralgia—Timolol—coronary artery disease	0.000147	0.000365	CcSEcCtD
Rifaximin—Myalgia—Timolol—coronary artery disease	0.000147	0.000365	CcSEcCtD
Rifaximin—Vomiting—Ezetimibe—coronary artery disease	0.000146	0.000364	CcSEcCtD
Rifaximin—Hypersensitivity—Pravastatin—coronary artery disease	0.000146	0.000364	CcSEcCtD
Rifaximin—Gastrointestinal pain—Perindopril—coronary artery disease	0.000146	0.000364	CcSEcCtD
Rifaximin—Angioedema—Lisinopril—coronary artery disease	0.000146	0.000363	CcSEcCtD
Rifaximin—Pruritus—Olmesartan—coronary artery disease	0.000146	0.000363	CcSEcCtD
Rifaximin—Decreased appetite—Losartan—coronary artery disease	0.000146	0.000363	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000146	0.000362	CcSEcCtD
Rifaximin—Body temperature increased—Captopril—coronary artery disease	0.000146	0.000362	CcSEcCtD
Rifaximin—Abdominal pain—Captopril—coronary artery disease	0.000146	0.000362	CcSEcCtD
Rifaximin—Dizziness—Simvastatin—coronary artery disease	0.000145	0.000361	CcSEcCtD
Rifaximin—Rash—Ezetimibe—coronary artery disease	0.000145	0.000361	CcSEcCtD
Rifaximin—Dermatitis—Ezetimibe—coronary artery disease	0.000145	0.000361	CcSEcCtD
Rifaximin—Confusional state—Ramipril—coronary artery disease	0.000145	0.000361	CcSEcCtD
Rifaximin—Discomfort—Timolol—coronary artery disease	0.000145	0.00036	CcSEcCtD
Rifaximin—Asthenia—Niacin—coronary artery disease	0.000145	0.00036	CcSEcCtD
Rifaximin—Fatigue—Losartan—coronary artery disease	0.000145	0.00036	CcSEcCtD
Rifaximin—Headache—Ezetimibe—coronary artery disease	0.000144	0.000359	CcSEcCtD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	0.000144	0.0047	CbGpPWpGaD
Rifaximin—Malaise—Lisinopril—coronary artery disease	0.000144	0.000358	CcSEcCtD
Rifaximin—Anaphylactic shock—Ramipril—coronary artery disease	0.000144	0.000358	CcSEcCtD
Rifaximin—Vertigo—Lisinopril—coronary artery disease	0.000144	0.000357	CcSEcCtD
Rifaximin—Dry mouth—Timolol—coronary artery disease	0.000143	0.000357	CcSEcCtD
Rifaximin—Constipation—Losartan—coronary artery disease	0.000143	0.000357	CcSEcCtD
Rifaximin—Pain—Losartan—coronary artery disease	0.000143	0.000357	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—ZFP36—coronary artery disease	0.000143	0.00467	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—YBX1—coronary artery disease	0.000143	0.00467	CbGpPWpGaD
Rifaximin—Syncope—Lisinopril—coronary artery disease	0.000143	0.000356	CcSEcCtD
Rifaximin—Vomiting—Eplerenone—coronary artery disease	0.000143	0.000356	CcSEcCtD
Rifaximin—Feeling abnormal—Furosemide—coronary artery disease	0.000143	0.000356	CcSEcCtD
Rifaximin—Nausea—Fenofibrate—coronary artery disease	0.000143	0.000355	CcSEcCtD
Rifaximin—Pruritus—Niacin—coronary artery disease	0.000143	0.000355	CcSEcCtD
Rifaximin—Asthenia—Pravastatin—coronary artery disease	0.000142	0.000354	CcSEcCtD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	0.000142	0.00464	CbGpPWpGaD
Rifaximin—Gastrointestinal pain—Furosemide—coronary artery disease	0.000142	0.000354	CcSEcCtD
Rifaximin—Rash—Eplerenone—coronary artery disease	0.000142	0.000353	CcSEcCtD
Rifaximin—Urticaria—Perindopril—coronary artery disease	0.000142	0.000353	CcSEcCtD
Rifaximin—Hypersensitivity—Trandolapril—coronary artery disease	0.000142	0.000353	CcSEcCtD
Rifaximin—Dermatitis—Eplerenone—coronary artery disease	0.000142	0.000353	CcSEcCtD
Rifaximin—Diarrhoea—Valsartan—coronary artery disease	0.000142	0.000353	CcSEcCtD
Rifaximin—Confusional state—Timolol—coronary artery disease	0.000142	0.000353	CcSEcCtD
Rifaximin—Shock—Ramipril—coronary artery disease	0.000142	0.000352	CcSEcCtD
Rifaximin—Hypersensitivity—Enalapril—coronary artery disease	0.000141	0.000352	CcSEcCtD
Rifaximin—Abdominal pain—Perindopril—coronary artery disease	0.000141	0.000352	CcSEcCtD
Rifaximin—Body temperature increased—Perindopril—coronary artery disease	0.000141	0.000352	CcSEcCtD
Rifaximin—Diarrhoea—Olmesartan—coronary artery disease	0.000141	0.000351	CcSEcCtD
Rifaximin—Headache—Eplerenone—coronary artery disease	0.000141	0.000351	CcSEcCtD
Rifaximin—Nervous system disorder—Ramipril—coronary artery disease	0.000141	0.000351	CcSEcCtD
Rifaximin—Anaphylactic shock—Timolol—coronary artery disease	0.000141	0.00035	CcSEcCtD
Rifaximin—Pruritus—Pravastatin—coronary artery disease	0.00014	0.000349	CcSEcCtD
Rifaximin—Loss of consciousness—Lisinopril—coronary artery disease	0.00014	0.000349	CcSEcCtD
Rifaximin—Nausea—Clopidogrel—coronary artery disease	0.00014	0.000349	CcSEcCtD
Rifaximin—Skin disorder—Ramipril—coronary artery disease	0.00014	0.000347	CcSEcCtD
Rifaximin—Infection—Timolol—coronary artery disease	0.00014	0.000347	CcSEcCtD
Rifaximin—Vomiting—Simvastatin—coronary artery disease	0.00014	0.000347	CcSEcCtD
Rifaximin—Hypersensitivity—Telmisartan—coronary artery disease	0.00014	0.000347	CcSEcCtD
Rifaximin—Cough—Lisinopril—coronary artery disease	0.000139	0.000347	CcSEcCtD
Rifaximin—Nausea—Lovastatin—coronary artery disease	0.000139	0.000347	CcSEcCtD
Rifaximin—Hyperhidrosis—Ramipril—coronary artery disease	0.000139	0.000346	CcSEcCtD
Rifaximin—Rash—Simvastatin—coronary artery disease	0.000138	0.000344	CcSEcCtD
Rifaximin—Dermatitis—Simvastatin—coronary artery disease	0.000138	0.000344	CcSEcCtD
Rifaximin—Asthenia—Trandolapril—coronary artery disease	0.000138	0.000344	CcSEcCtD
Rifaximin—Shock—Timolol—coronary artery disease	0.000138	0.000344	CcSEcCtD
Rifaximin—Feeling abnormal—Losartan—coronary artery disease	0.000138	0.000344	CcSEcCtD
Rifaximin—Urticaria—Furosemide—coronary artery disease	0.000138	0.000344	CcSEcCtD
Rifaximin—Diarrhoea—Niacin—coronary artery disease	0.000138	0.000343	CcSEcCtD
Rifaximin—Nervous system disorder—Timolol—coronary artery disease	0.000138	0.000343	CcSEcCtD
Rifaximin—Asthenia—Enalapril—coronary artery disease	0.000138	0.000343	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—JUNB—coronary artery disease	0.000138	0.00449	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ESR2—coronary artery disease	0.000138	0.00449	CbGpPWpGaD
Rifaximin—Headache—Simvastatin—coronary artery disease	0.000138	0.000342	CcSEcCtD
Rifaximin—Abdominal pain—Furosemide—coronary artery disease	0.000137	0.000342	CcSEcCtD
Rifaximin—Body temperature increased—Furosemide—coronary artery disease	0.000137	0.000342	CcSEcCtD
Rifaximin—Gastrointestinal pain—Losartan—coronary artery disease	0.000137	0.000341	CcSEcCtD
Rifaximin—Dizziness—Valsartan—coronary artery disease	0.000137	0.000341	CcSEcCtD
Rifaximin—Anorexia—Ramipril—coronary artery disease	0.000137	0.000341	CcSEcCtD
Rifaximin—Nausea—Ezetimibe—coronary artery disease	0.000137	0.00034	CcSEcCtD
Rifaximin—Skin disorder—Timolol—coronary artery disease	0.000137	0.00034	CcSEcCtD
Rifaximin—Dizziness—Olmesartan—coronary artery disease	0.000136	0.000339	CcSEcCtD
Rifaximin—Pruritus—Trandolapril—coronary artery disease	0.000136	0.000339	CcSEcCtD
Rifaximin—Chest pain—Lisinopril—coronary artery disease	0.000136	0.000338	CcSEcCtD
Rifaximin—Arthralgia—Lisinopril—coronary artery disease	0.000136	0.000338	CcSEcCtD
Rifaximin—Myalgia—Lisinopril—coronary artery disease	0.000136	0.000338	CcSEcCtD
Rifaximin—Hyperhidrosis—Timolol—coronary artery disease	0.000136	0.000338	CcSEcCtD
Rifaximin—Asthenia—Telmisartan—coronary artery disease	0.000136	0.000338	CcSEcCtD
Rifaximin—Pruritus—Enalapril—coronary artery disease	0.000136	0.000338	CcSEcCtD
Rifaximin—Diarrhoea—Pravastatin—coronary artery disease	0.000136	0.000338	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000135	0.000336	CcSEcCtD
Rifaximin—Discomfort—Lisinopril—coronary artery disease	0.000134	0.000334	CcSEcCtD
Rifaximin—Hypotension—Ramipril—coronary artery disease	0.000134	0.000334	CcSEcCtD
Rifaximin—Anorexia—Timolol—coronary artery disease	0.000134	0.000333	CcSEcCtD
Rifaximin—Pruritus—Telmisartan—coronary artery disease	0.000134	0.000333	CcSEcCtD
Rifaximin—Nausea—Eplerenone—coronary artery disease	0.000134	0.000333	CcSEcCtD
Rifaximin—Dizziness—Niacin—coronary artery disease	0.000133	0.000332	CcSEcCtD
Rifaximin—Urticaria—Losartan—coronary artery disease	0.000133	0.000331	CcSEcCtD
Rifaximin—Dry mouth—Lisinopril—coronary artery disease	0.000133	0.000331	CcSEcCtD
Rifaximin—Abdominal pain—Losartan—coronary artery disease	0.000133	0.00033	CcSEcCtD
Rifaximin—Body temperature increased—Losartan—coronary artery disease	0.000133	0.00033	CcSEcCtD
Rifaximin—Asthenia—Captopril—coronary artery disease	0.000132	0.000329	CcSEcCtD
Rifaximin—Diarrhoea—Trandolapril—coronary artery disease	0.000132	0.000328	CcSEcCtD
Rifaximin—Vomiting—Valsartan—coronary artery disease	0.000132	0.000328	CcSEcCtD
Rifaximin—Confusional state—Lisinopril—coronary artery disease	0.000132	0.000327	CcSEcCtD
Rifaximin—Diarrhoea—Enalapril—coronary artery disease	0.000131	0.000327	CcSEcCtD
Rifaximin—Hypotension—Timolol—coronary artery disease	0.000131	0.000327	CcSEcCtD
Rifaximin—Dizziness—Pravastatin—coronary artery disease	0.000131	0.000327	CcSEcCtD
Rifaximin—Vomiting—Olmesartan—coronary artery disease	0.000131	0.000326	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000131	0.000326	CcSEcCtD
Rifaximin—Rash—Valsartan—coronary artery disease	0.000131	0.000325	CcSEcCtD
Rifaximin—Dermatitis—Valsartan—coronary artery disease	0.000131	0.000325	CcSEcCtD
Rifaximin—Nausea—Simvastatin—coronary artery disease	0.00013	0.000324	CcSEcCtD
Rifaximin—Anaphylactic shock—Lisinopril—coronary artery disease	0.00013	0.000324	CcSEcCtD
Rifaximin—Pruritus—Captopril—coronary artery disease	0.00013	0.000324	CcSEcCtD
Rifaximin—Rash—Olmesartan—coronary artery disease	0.00013	0.000324	CcSEcCtD
Rifaximin—Insomnia—Ramipril—coronary artery disease	0.00013	0.000324	CcSEcCtD
Rifaximin—Dermatitis—Olmesartan—coronary artery disease	0.00013	0.000323	CcSEcCtD
Rifaximin—Headache—Valsartan—coronary artery disease	0.00013	0.000323	CcSEcCtD
Rifaximin—Diarrhoea—Telmisartan—coronary artery disease	0.00013	0.000322	CcSEcCtD
Rifaximin—Infection—Lisinopril—coronary artery disease	0.00013	0.000322	CcSEcCtD
Rifaximin—Headache—Olmesartan—coronary artery disease	0.000129	0.000322	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—RPL17—coronary artery disease	0.000129	0.00419	CbGpPWpGaD
Rifaximin—Shock—Lisinopril—coronary artery disease	0.000128	0.000319	CcSEcCtD
Rifaximin—Asthenia—Perindopril—coronary artery disease	0.000128	0.000319	CcSEcCtD
Rifaximin—Dyspnoea—Ramipril—coronary artery disease	0.000128	0.000319	CcSEcCtD
Rifaximin—Vomiting—Niacin—coronary artery disease	0.000128	0.000319	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000128	0.000319	CcSEcCtD
Rifaximin—Hypersensitivity—Furosemide—coronary artery disease	0.000128	0.000319	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	0.000128	0.00416	CbGpPWpGaD
Rifaximin—Dizziness—Trandolapril—coronary artery disease	0.000128	0.000317	CcSEcCtD
Rifaximin—Insomnia—Timolol—coronary artery disease	0.000127	0.000316	CcSEcCtD
Rifaximin—Rash—Niacin—coronary artery disease	0.000127	0.000316	CcSEcCtD
Rifaximin—Dermatitis—Niacin—coronary artery disease	0.000127	0.000316	CcSEcCtD
Rifaximin—Dizziness—Enalapril—coronary artery disease	0.000127	0.000316	CcSEcCtD
Rifaximin—Skin disorder—Lisinopril—coronary artery disease	0.000127	0.000315	CcSEcCtD
Rifaximin—Pruritus—Perindopril—coronary artery disease	0.000127	0.000315	CcSEcCtD
Rifaximin—Headache—Niacin—coronary artery disease	0.000126	0.000314	CcSEcCtD
Rifaximin—Vomiting—Pravastatin—coronary artery disease	0.000126	0.000314	CcSEcCtD
Rifaximin—Hyperhidrosis—Lisinopril—coronary artery disease	0.000126	0.000314	CcSEcCtD
Rifaximin—Diarrhoea—Captopril—coronary artery disease	0.000126	0.000313	CcSEcCtD
Rifaximin—Dyspnoea—Timolol—coronary artery disease	0.000125	0.000312	CcSEcCtD
Rifaximin—Dizziness—Telmisartan—coronary artery disease	0.000125	0.000312	CcSEcCtD
Rifaximin—Rash—Pravastatin—coronary artery disease	0.000125	0.000311	CcSEcCtD
Rifaximin—Dermatitis—Pravastatin—coronary artery disease	0.000125	0.000311	CcSEcCtD
Rifaximin—Decreased appetite—Ramipril—coronary artery disease	0.000125	0.000311	CcSEcCtD
Rifaximin—Asthenia—Furosemide—coronary artery disease	0.000125	0.00031	CcSEcCtD
Rifaximin—Headache—Pravastatin—coronary artery disease	0.000124	0.000309	CcSEcCtD
Rifaximin—Anorexia—Lisinopril—coronary artery disease	0.000124	0.000309	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000124	0.000309	CcSEcCtD
Rifaximin—Fatigue—Ramipril—coronary artery disease	0.000124	0.000308	CcSEcCtD
Rifaximin—Hypersensitivity—Losartan—coronary artery disease	0.000124	0.000307	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.000123	0.00401	CbGpPWpGaD
Rifaximin—Nausea—Valsartan—coronary artery disease	0.000123	0.000306	CcSEcCtD
Rifaximin—Pruritus—Furosemide—coronary artery disease	0.000123	0.000306	CcSEcCtD
Rifaximin—Constipation—Ramipril—coronary artery disease	0.000123	0.000306	CcSEcCtD
Rifaximin—Nausea—Olmesartan—coronary artery disease	0.000123	0.000305	CcSEcCtD
Rifaximin—Vomiting—Trandolapril—coronary artery disease	0.000123	0.000305	CcSEcCtD
Rifaximin—Diarrhoea—Perindopril—coronary artery disease	0.000122	0.000304	CcSEcCtD
Rifaximin—Decreased appetite—Timolol—coronary artery disease	0.000122	0.000304	CcSEcCtD
Rifaximin—Vomiting—Enalapril—coronary artery disease	0.000122	0.000304	CcSEcCtD
Rifaximin—Hypotension—Lisinopril—coronary artery disease	0.000122	0.000303	CcSEcCtD
Rifaximin—Dizziness—Captopril—coronary artery disease	0.000122	0.000303	CcSEcCtD
Rifaximin—Rash—Trandolapril—coronary artery disease	0.000122	0.000302	CcSEcCtD
Rifaximin—Dermatitis—Trandolapril—coronary artery disease	0.000121	0.000302	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Timolol—coronary artery disease	0.000121	0.000302	CcSEcCtD
Rifaximin—Fatigue—Timolol—coronary artery disease	0.000121	0.000302	CcSEcCtD
Rifaximin—Rash—Enalapril—coronary artery disease	0.000121	0.000301	CcSEcCtD
Rifaximin—Dermatitis—Enalapril—coronary artery disease	0.000121	0.000301	CcSEcCtD
Rifaximin—Headache—Trandolapril—coronary artery disease	0.000121	0.0003	CcSEcCtD
Rifaximin—Vomiting—Telmisartan—coronary artery disease	0.00012	0.0003	CcSEcCtD
Rifaximin—Asthenia—Losartan—coronary artery disease	0.00012	0.000299	CcSEcCtD
Rifaximin—Headache—Enalapril—coronary artery disease	0.00012	0.000299	CcSEcCtD
Rifaximin—Pain—Timolol—coronary artery disease	0.00012	0.000299	CcSEcCtD
Rifaximin—Nausea—Niacin—coronary artery disease	0.00012	0.000298	CcSEcCtD
Rifaximin—Rash—Telmisartan—coronary artery disease	0.000119	0.000297	CcSEcCtD
Rifaximin—Dermatitis—Telmisartan—coronary artery disease	0.000119	0.000297	CcSEcCtD
Rifaximin—Diarrhoea—Furosemide—coronary artery disease	0.000119	0.000296	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000119	0.000296	CcSEcCtD
Rifaximin—Pruritus—Losartan—coronary artery disease	0.000119	0.000295	CcSEcCtD
Rifaximin—Headache—Telmisartan—coronary artery disease	0.000119	0.000295	CcSEcCtD
Rifaximin—Feeling abnormal—Ramipril—coronary artery disease	0.000119	0.000295	CcSEcCtD
Rifaximin—Dizziness—Perindopril—coronary artery disease	0.000118	0.000294	CcSEcCtD
Rifaximin—Insomnia—Lisinopril—coronary artery disease	0.000118	0.000293	CcSEcCtD
Rifaximin—Nausea—Pravastatin—coronary artery disease	0.000118	0.000293	CcSEcCtD
Rifaximin—Gastrointestinal pain—Ramipril—coronary artery disease	0.000118	0.000293	CcSEcCtD
Rifaximin—Vomiting—Captopril—coronary artery disease	0.000117	0.000291	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	0.000117	0.00381	CbGpPWpGaD
Rifaximin—Dyspnoea—Lisinopril—coronary artery disease	0.000116	0.000289	CcSEcCtD
Rifaximin—Rash—Captopril—coronary artery disease	0.000116	0.000289	CcSEcCtD
Rifaximin—Dermatitis—Captopril—coronary artery disease	0.000116	0.000289	CcSEcCtD
Rifaximin—Feeling abnormal—Timolol—coronary artery disease	0.000116	0.000288	CcSEcCtD
Rifaximin—Headache—Captopril—coronary artery disease	0.000115	0.000287	CcSEcCtD
Rifaximin—Gastrointestinal pain—Timolol—coronary artery disease	0.000115	0.000286	CcSEcCtD
Rifaximin—Dizziness—Furosemide—coronary artery disease	0.000115	0.000286	CcSEcCtD
Rifaximin—Diarrhoea—Losartan—coronary artery disease	0.000115	0.000285	CcSEcCtD
Rifaximin—Nausea—Trandolapril—coronary artery disease	0.000115	0.000285	CcSEcCtD
Rifaximin—Urticaria—Ramipril—coronary artery disease	0.000114	0.000284	CcSEcCtD
Rifaximin—Nausea—Enalapril—coronary artery disease	0.000114	0.000284	CcSEcCtD
Rifaximin—Vomiting—Perindopril—coronary artery disease	0.000114	0.000283	CcSEcCtD
Rifaximin—Abdominal pain—Ramipril—coronary artery disease	0.000114	0.000283	CcSEcCtD
Rifaximin—Body temperature increased—Ramipril—coronary artery disease	0.000114	0.000283	CcSEcCtD
Rifaximin—Decreased appetite—Lisinopril—coronary artery disease	0.000113	0.000282	CcSEcCtD
Rifaximin—Rash—Perindopril—coronary artery disease	0.000113	0.00028	CcSEcCtD
Rifaximin—Dermatitis—Perindopril—coronary artery disease	0.000113	0.00028	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000113	0.00028	CcSEcCtD
Rifaximin—Nausea—Telmisartan—coronary artery disease	0.000113	0.00028	CcSEcCtD
Rifaximin—Fatigue—Lisinopril—coronary artery disease	0.000112	0.00028	CcSEcCtD
Rifaximin—Headache—Perindopril—coronary artery disease	0.000112	0.000279	CcSEcCtD
Rifaximin—Urticaria—Timolol—coronary artery disease	0.000112	0.000278	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	0.000112	0.00364	CbGpPWpGaD
Rifaximin—Pain—Lisinopril—coronary artery disease	0.000112	0.000277	CcSEcCtD
Rifaximin—Constipation—Lisinopril—coronary artery disease	0.000112	0.000277	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	0.000111	0.00363	CbGpPWpGaD
Rifaximin—Abdominal pain—Timolol—coronary artery disease	0.000111	0.000276	CcSEcCtD
Rifaximin—Body temperature increased—Timolol—coronary artery disease	0.000111	0.000276	CcSEcCtD
Rifaximin—Dizziness—Losartan—coronary artery disease	0.000111	0.000276	CcSEcCtD
Rifaximin—Vomiting—Furosemide—coronary artery disease	0.000111	0.000275	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	0.00011	0.00359	CbGpPWpGaD
Rifaximin—Rash—Furosemide—coronary artery disease	0.00011	0.000273	CcSEcCtD
Rifaximin—Dermatitis—Furosemide—coronary artery disease	0.00011	0.000272	CcSEcCtD
Rifaximin—Nausea—Captopril—coronary artery disease	0.000109	0.000272	CcSEcCtD
Rifaximin—Headache—Furosemide—coronary artery disease	0.000109	0.000271	CcSEcCtD
Rifaximin—Feeling abnormal—Lisinopril—coronary artery disease	0.000107	0.000267	CcSEcCtD
Rifaximin—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000107	0.000265	CcSEcCtD
Rifaximin—Vomiting—Losartan—coronary artery disease	0.000107	0.000265	CcSEcCtD
Rifaximin—Nausea—Perindopril—coronary artery disease	0.000106	0.000264	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—GATA4—coronary artery disease	0.000106	0.00346	CbGpPWpGaD
Rifaximin—Hypersensitivity—Ramipril—coronary artery disease	0.000106	0.000264	CcSEcCtD
Rifaximin—Rash—Losartan—coronary artery disease	0.000106	0.000263	CcSEcCtD
Rifaximin—Dermatitis—Losartan—coronary artery disease	0.000106	0.000263	CcSEcCtD
Rifaximin—Headache—Losartan—coronary artery disease	0.000105	0.000261	CcSEcCtD
Rifaximin—Urticaria—Lisinopril—coronary artery disease	0.000104	0.000258	CcSEcCtD
Rifaximin—Hypersensitivity—Timolol—coronary artery disease	0.000104	0.000258	CcSEcCtD
Rifaximin—Nausea—Furosemide—coronary artery disease	0.000103	0.000257	CcSEcCtD
Rifaximin—Asthenia—Ramipril—coronary artery disease	0.000103	0.000257	CcSEcCtD
Rifaximin—Body temperature increased—Lisinopril—coronary artery disease	0.000103	0.000256	CcSEcCtD
Rifaximin—Abdominal pain—Lisinopril—coronary artery disease	0.000103	0.000256	CcSEcCtD
Rifaximin—Pruritus—Ramipril—coronary artery disease	0.000102	0.000253	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NR4A1—coronary artery disease	0.000101	0.00331	CbGpPWpGaD
Rifaximin—Asthenia—Timolol—coronary artery disease	0.000101	0.000251	CcSEcCtD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	0.000101	0.00328	CbGpPWpGaD
Rifaximin—Nausea—Losartan—coronary artery disease	9.96e-05	0.000248	CcSEcCtD
Rifaximin—Pruritus—Timolol—coronary artery disease	9.95e-05	0.000247	CcSEcCtD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	9.93e-05	0.00323	CbGpPWpGaD
Rifaximin—Diarrhoea—Ramipril—coronary artery disease	9.84e-05	0.000245	CcSEcCtD
Rifaximin—Diarrhoea—Timolol—coronary artery disease	9.62e-05	0.000239	CcSEcCtD
Rifaximin—Hypersensitivity—Lisinopril—coronary artery disease	9.61e-05	0.000239	CcSEcCtD
Rifaximin—Dizziness—Ramipril—coronary artery disease	9.51e-05	0.000237	CcSEcCtD
Rifaximin—Asthenia—Lisinopril—coronary artery disease	9.36e-05	0.000233	CcSEcCtD
Rifaximin—Dizziness—Timolol—coronary artery disease	9.3e-05	0.000231	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NPPA—coronary artery disease	9.24e-05	0.00301	CbGpPWpGaD
Rifaximin—Pruritus—Lisinopril—coronary artery disease	9.23e-05	0.00023	CcSEcCtD
Rifaximin—Vomiting—Ramipril—coronary artery disease	9.15e-05	0.000227	CcSEcCtD
Rifaximin—Rash—Ramipril—coronary artery disease	9.07e-05	0.000226	CcSEcCtD
Rifaximin—Dermatitis—Ramipril—coronary artery disease	9.06e-05	0.000225	CcSEcCtD
Rifaximin—Headache—Ramipril—coronary artery disease	9.01e-05	0.000224	CcSEcCtD
Rifaximin—Vomiting—Timolol—coronary artery disease	8.94e-05	0.000222	CcSEcCtD
Rifaximin—Diarrhoea—Lisinopril—coronary artery disease	8.93e-05	0.000222	CcSEcCtD
Rifaximin—Rash—Timolol—coronary artery disease	8.87e-05	0.000221	CcSEcCtD
Rifaximin—Dermatitis—Timolol—coronary artery disease	8.86e-05	0.00022	CcSEcCtD
Rifaximin—Headache—Timolol—coronary artery disease	8.81e-05	0.000219	CcSEcCtD
Rifaximin—Dizziness—Lisinopril—coronary artery disease	8.63e-05	0.000215	CcSEcCtD
Rifaximin—Nausea—Ramipril—coronary artery disease	8.54e-05	0.000212	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	8.37e-05	0.00273	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ESR1—coronary artery disease	8.35e-05	0.00272	CbGpPWpGaD
Rifaximin—Nausea—Timolol—coronary artery disease	8.35e-05	0.000208	CcSEcCtD
Rifaximin—Vomiting—Lisinopril—coronary artery disease	8.29e-05	0.000206	CcSEcCtD
Rifaximin—Rash—Lisinopril—coronary artery disease	8.22e-05	0.000205	CcSEcCtD
Rifaximin—Dermatitis—Lisinopril—coronary artery disease	8.22e-05	0.000204	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	8.19e-05	0.00267	CbGpPWpGaD
Rifaximin—Headache—Lisinopril—coronary artery disease	8.17e-05	0.000203	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	8.15e-05	0.00266	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	7.96e-05	0.00259	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	7.85e-05	0.00256	CbGpPWpGaD
Rifaximin—Nausea—Lisinopril—coronary artery disease	7.75e-05	0.000193	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARG—coronary artery disease	7.62e-05	0.00248	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	7.54e-05	0.00246	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	7.44e-05	0.00242	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PSMB5—coronary artery disease	7.42e-05	0.00242	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PSMA6—coronary artery disease	7.42e-05	0.00242	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—CTGF—coronary artery disease	7.25e-05	0.00236	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	7.1e-05	0.00231	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	7.06e-05	0.0023	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—SERPINE1—coronary artery disease	6.87e-05	0.00224	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—JUNB—coronary artery disease	6.63e-05	0.00216	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ESR2—coronary artery disease	6.63e-05	0.00216	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HSPA1A—coronary artery disease	6.63e-05	0.00216	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GCLM—coronary artery disease	6.41e-05	0.00209	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	6.21e-05	0.00202	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	6.13e-05	0.002	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	5.65e-05	0.00184	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	5.64e-05	0.00184	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	5.57e-05	0.00181	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	5.57e-05	0.00181	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	5.51e-05	0.0018	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SIRT1—coronary artery disease	5.34e-05	0.00174	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPP2CA—coronary artery disease	4.72e-05	0.00154	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PRKCD—coronary artery disease	4.63e-05	0.00151	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	4.57e-05	0.00149	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	4.44e-05	0.00145	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	4.42e-05	0.00144	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	4.33e-05	0.00141	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	4.27e-05	0.00139	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	4.23e-05	0.00138	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GCLC—coronary artery disease	4.18e-05	0.00136	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—MAPK14—coronary artery disease	4.1e-05	0.00134	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ESR1—coronary artery disease	4.02e-05	0.00131	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARG—coronary artery disease	3.67e-05	0.0012	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	3.58e-05	0.00117	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SERPINE1—coronary artery disease	3.31e-05	0.00108	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GGT1—coronary artery disease	3.26e-05	0.00106	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA5B—coronary artery disease	2.96e-05	0.000965	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	2.93e-05	0.000955	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	2.89e-05	0.000942	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	2.69e-05	0.000877	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	2.66e-05	0.000865	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CKMT1B—coronary artery disease	2.52e-05	0.000821	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CKM—coronary artery disease	2.05e-05	0.000669	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.05e-05	0.000669	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.05e-05	0.000669	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PYGM—coronary artery disease	1.91e-05	0.000622	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SULT4A1—coronary artery disease	1.91e-05	0.000622	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PDK4—coronary artery disease	1.91e-05	0.000622	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	1.91e-05	0.000622	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CKMT2—coronary artery disease	1.91e-05	0.000622	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—POMC—coronary artery disease	1.9e-05	0.00062	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMGCS2—coronary artery disease	1.7e-05	0.000554	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GYG1—coronary artery disease	1.7e-05	0.000554	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GK—coronary artery disease	1.7e-05	0.000554	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PFKM—coronary artery disease	1.7e-05	0.000554	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LDHA—coronary artery disease	1.7e-05	0.000554	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GATM—coronary artery disease	1.7e-05	0.000554	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AK1—coronary artery disease	1.62e-05	0.000529	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCH1—coronary artery disease	1.62e-05	0.000529	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MDH2—coronary artery disease	1.56e-05	0.000507	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UGCG—coronary artery disease	1.56e-05	0.000507	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.56e-05	0.000507	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPAT—coronary artery disease	1.56e-05	0.000507	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PGM1—coronary artery disease	1.5e-05	0.000488	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AKT1—coronary artery disease	1.45e-05	0.000473	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CKB—coronary artery disease	1.45e-05	0.000471	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PYGB—coronary artery disease	1.45e-05	0.000471	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.36e-05	0.000443	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COX5B—coronary artery disease	1.36e-05	0.000443	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.36e-05	0.000443	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DLAT—coronary artery disease	1.36e-05	0.000443	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.36e-05	0.000443	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.29e-05	0.00042	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HK2—coronary artery disease	1.23e-05	0.000401	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.23e-05	0.000401	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.18e-05	0.000384	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LCAT—coronary artery disease	1.16e-05	0.000377	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.16e-05	0.000377	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA4—coronary artery disease	1.14e-05	0.00037	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.1e-05	0.000357	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCLM—coronary artery disease	1.1e-05	0.000357	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.06e-05	0.000346	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.06e-05	0.000346	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.05e-05	0.000341	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HADH—coronary artery disease	1.03e-05	0.000336	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.03e-05	0.000336	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA2—coronary artery disease	9.77e-06	0.000318	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX2—coronary artery disease	9.77e-06	0.000318	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	9.77e-06	0.000318	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HK1—coronary artery disease	9.65e-06	0.000315	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCG5—coronary artery disease	9.65e-06	0.000315	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX4—coronary artery disease	9.65e-06	0.000315	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	9.65e-06	0.000315	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HADHA—coronary artery disease	9.54e-06	0.000311	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTA1—coronary artery disease	9.43e-06	0.000307	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPA—coronary artery disease	9.32e-06	0.000304	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLCB3—coronary artery disease	9.03e-06	0.000294	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA5—coronary artery disease	8.94e-06	0.000291	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—P4HB—coronary artery disease	8.77e-06	0.000286	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	8.61e-06	0.00028	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—VCAN—coronary artery disease	8.11e-06	0.000264	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDOA—coronary artery disease	8.05e-06	0.000262	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DCN—coronary artery disease	7.81e-06	0.000255	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH2—coronary artery disease	7.6e-06	0.000248	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HBA1—coronary artery disease	7.41e-06	0.000241	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LIPC—coronary artery disease	7.41e-06	0.000241	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	7.41e-06	0.000241	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	7.41e-06	0.000241	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOC3—coronary artery disease	7.36e-06	0.00024	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LDLR—coronary artery disease	7.32e-06	0.000238	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTT1—coronary artery disease	7.23e-06	0.000236	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	7.23e-06	0.000236	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CETP—coronary artery disease	7.15e-06	0.000233	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GCLC—coronary artery disease	7.15e-06	0.000233	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SDC1—coronary artery disease	7.07e-06	0.00023	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PSMA6—coronary artery disease	6.68e-06	0.000217	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PSMB5—coronary artery disease	6.68e-06	0.000217	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CTGF—coronary artery disease	6.52e-06	0.000212	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMGCR—coronary artery disease	6.46e-06	0.000211	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT2—coronary artery disease	6.46e-06	0.000211	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.94e-06	0.000194	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.76e-06	0.000188	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT1—coronary artery disease	5.58e-06	0.000182	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GGT1—coronary artery disease	5.58e-06	0.000182	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.01e-06	0.000163	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.97e-06	0.000162	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.94e-06	0.000161	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CAT—coronary artery disease	4.88e-06	0.000159	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOB—coronary artery disease	4.73e-06	0.000154	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.61e-06	0.00015	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LPL—coronary artery disease	4.52e-06	0.000147	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX1—coronary artery disease	4.41e-06	0.000144	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CD36—coronary artery disease	4.3e-06	0.00014	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.24e-06	0.000138	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.07e-06	0.000133	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AGT—coronary artery disease	3.87e-06	0.000126	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOE—coronary artery disease	3.79e-06	0.000123	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA1—coronary artery disease	3.75e-06	0.000122	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARG—coronary artery disease	3.3e-06	0.000108	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—POMC—coronary artery disease	3.26e-06	0.000106	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—coronary artery disease	2.97e-06	9.67e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NOS3—coronary artery disease	2.84e-06	9.25e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.6e-06	8.46e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.6e-06	5.2e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKT1—coronary artery disease	1.3e-06	4.25e-05	CbGpPWpGaD
